Overview

Multiplex Assay Market is poised to value over USD 4.14 billion by 2027 end at a CAGR of over 7.2% during the forecast period 2020 to 2027.

The growing acceptance of companion diagnostics for increasing the efficacy and safety of therapeutics and the benefits of multiplex assays over traditional single plex assays are some of the major factors responsible for the multiplex assay market growth. Multiplex assays profile different analytes like biomolecules, proteins, chemokines, cytokines by quantifying and detecting them at the same time. These assays are used for amplifying different targets in a PCR and for collecting more insights from miniscule protein quantities in less time in comparison to traditional methods like ELISA. The assays are prominently utilized for identifying pathogens, analysis of mutations, gene detection analysis, RNA detection, forensic studies, linkage analysis, etc. The rising research and development activities for treating multiple disorders shall bolster the proliferation of the market.
Conventional anticancer therapies have used multiples assays in limited ways. The TDM offers valuable insights for the adjusting the dosage of immunosuppressants, antiepileptics, antibiotics and other drugs. The necessity of different samples of blood for defining the exposure of anticancer drugs systematically has been one of the key problems while testing the therapeutics for anticancer. However, the TDM services are expensive and small hospitals, especially in developing nations, are reluctant on providing these services which is one of the key limiting factors responsible for the growth of the market.

Multiplex Assay Market Segmentation:
By Product and Service
• Consumables
• Instruments
• Software and Services
By Type
• Protein Multiplex Assays
o Planar Protein Assays
o Bead-Based Protein Assays
o Other Protein Assays
• Nucleic Acid Multiplex Assays
o Planar Nucleic Acid Assays
o Bead-Based Nucleic Acid Assays
o Other Nucleic Acid Assays
• Cell-Based Multiplex Assays
By Technology
• Flow Cytometry
• Fluorescence Detection
• Luminescence
• Multiplex Real-Time PCR
• Other Technologies
By Application
• Research & Development
o Drug Discovery & Development
o Biomarker Discovery & Validation
• Clinical Diagnostics
o Infectious Diseases
o Cancer
o Cardiovascular Diseases
o Autoimmune Diseases
o Nervous System Disorders
o Metabolism & Endocrinology Disorders
o Other Diseases
By End User
• Pharmaceutical & Biotechnology Companies
• Hospitals & Research Institutes
• Reference Laboratories
• Other End Users
By Region
•   North America
•   Europe
•   Asia Pacific
•   Latin America
•   Middle East & Africa

The market is fragmented into product, type, application, end user and region. The product segment is categorized into consumables and equipment. The consumables segment is predicted to hold the largest multiples assays market share due to the necessity of repeated purchase of reagents along with the rise in the number of tests performed worldwide. The type segment is diversified into nuclei acid and protein cell. The technology segment is classified into luminescence and flow cytometry. The end user segment is divided into pharma & biotech, reference laboratory and hospital.

Regional Analysis:
The North America region is anticipated to lead the market owing to the rising per capita expenditure on healthcare, technological advancements in healthcare infrastructure, growing initiatives by the government bodies, increased disposable income.

Competitive Landscape:
Some of the key market players associated are Abbott Laboratories, Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Biomérieux, Bühlmann Laboratories, Sekisui Medical, Randox Laboratories.

FutureWise Key Takeaways:
•   Growth prospects
•   SWOT analysis
•   Key market trends
•   Key data-points affecting market growth

Objectives of the Study:
•   To provide with an exhaustive analysis on the global multiplex assays market by product, by type, by technology, by application, by end user and by region
•   To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•   To evaluate and forecast micro-markets and the overall market
•   To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•   To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers, and expansions

Flexible Delivery Model:
•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com